Found 0 matching trials
Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer PHASE2 The purpose of this study is to find out what effects (good and/or bad) a t...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia NA This study aims to evaluate the safety and effectiveness of combining venet...
Show More Status
Active Not Recruiting
Location
Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road
Learn More & Join Trial
Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia PHASE3 Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leuke...
Show More Location
French-Belgian-Swiss APL study group
Learn More & Join Trial
All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) PHASE3 The project was undertaking by Qilu Hospital of Shandong University in Chin...
Show More Location
Qilu Hospital, Shandong University
Learn More & Join Trial
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors PHASE2 This is a prospective, randomized, open-label, active-controlled study to e...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM) PHASE2 GO-A-HAM:
Gemtuzumab Ozogamicin 3g/m² day 1 Cytarabine 3g/m² bid days 1-3 ...
Show More Location
Department of Hematology / Oncology, University Hospital of Innsbruck
Learn More & Join Trial
Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result PHASE3 The concept of the investigators risk-adapted multicenter treatment trial f...
Show More Location
Department of Hematology / Oncology, University Hospital of Innsbruck
Learn More & Join Trial
Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) PHASE3 The investigators design a multicenter randomized controlled trial to prove...
Show More Location
First Affiliated Hospital of Xi'an Jiaotong University
Learn More & Join Trial
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer PHASE1 This phase Ib trial is to find out the best dose and side effects of all-tr...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) PHASE1 Substudy 02A is part of a larger research study that is testing experimenta...
Show More Location
The Angeles Clinic and Research Institute ( Site 1009)
Learn More & Join Trial